RESPINOR general news

RESPINOR awarded 14.2M NOKs from the Research Council of Norway

By 11. December 2020 No Comments

Christmas arrived early! We are pleased to announce that RESPINOR has secured 14.2M NOKs in soft funding from the Research Council of Norway to perform our pivotal study (DE-RISK WF) which will commence in Q1-2021! This will take us one step further to secure that our breakthrough technology, RESPINOR DXT, will be available for critically ill patients on mechanical ventilation world wide.

Thank you to the Research Council of Norway for supporting innovation in Norway within MedTech!